Insider Transactions Reported by 8 Insiders of Acurx Pharmaceuticals, Inc.

Symbol
ACXP on Nasdaq
Location
Staten Island, NY

There are no Buy or Sell transactions made by insiders since 17 Mar 2025

Acurx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Luci President and CEO, Director, 10%+ Owner $1,164,754 05 Feb 2025
DELUCCIA ROBERT J Director, 10%+ Owner $1,029,254 05 Feb 2025
Carl V Sailer Director $144,316 06 Jan 2025
Joseph C. Scodari Director $28,124 06 Jan 2025
Jack H. Dean Director $27,960 06 Jan 2025
James J. Donohue Director $22,687 06 Jan 2025
Robert G. Shawah Chief Financial Officer 05 Feb 2025
Thomas L. Harrison Director 17 Jun 2024

Recent Insider Transactions by Companies or Individuals for Acurx Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.